179 related articles for article (PubMed ID: 25089371)
1. Roles of circulating WNT-signaling proteins and WNT-inhibitors in human adiposity, insulin resistance, insulin secretion, and inflammation.
Almario RU; Karakas SE
Horm Metab Res; 2015 Feb; 47(2):152-7. PubMed ID: 25089371
[TBL] [Abstract][Full Text] [Related]
2. Sfrp5 correlates with insulin resistance and oxidative stress.
Carstensen M; Herder C; Kempf K; Erlund I; Martin S; Koenig W; Sundvall J; Bidel S; Kuha S; Roden M; Tuomilehto J
Eur J Clin Invest; 2013 Apr; 43(4):350-7. PubMed ID: 23398169
[TBL] [Abstract][Full Text] [Related]
3. Balanced duo of anti-inflammatory SFRP5 and proinflammatory WNT5A in children.
Prats-Puig A; Soriano-Rodríguez P; Carreras-Badosa G; Riera-Pérez E; Ros-Miquel M; Gomila-Borja A; de Zegher F; Ibáñez L; Bassols J; López-Bermejo A
Pediatr Res; 2014 Jun; 75(6):793-7. PubMed ID: 24603290
[TBL] [Abstract][Full Text] [Related]
4. Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans.
Hu W; Li L; Yang M; Luo X; Ran W; Liu D; Xiong Z; Liu H; Yang G
J Clin Endocrinol Metab; 2013 Jan; 98(1):290-8. PubMed ID: 23185036
[TBL] [Abstract][Full Text] [Related]
5. Circulating secreted frizzled-related protein 5 (Sfrp5) and wingless-type MMTV integration site family member 5a (Wnt5a) levels in patients with type 2 diabetes mellitus.
Lu YC; Wang CP; Hsu CC; Chiu CA; Yu TH; Hung WC; Lu LF; Chung FM; Tsai IT; Lin HC; Lee YJ
Diabetes Metab Res Rev; 2013 Oct; 29(7):551-6. PubMed ID: 23653377
[TBL] [Abstract][Full Text] [Related]
6. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
Holte J; Bergh T; Berne C; Lithell H
Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
[TBL] [Abstract][Full Text] [Related]
7. Novel adipokines WISP1 and betatrophin in PCOS: relationship to AMH levels, atherogenic and metabolic profile.
Sahin Ersoy G; Altun Ensari T; Vatansever D; Emirdar V; Cevik O
Gynecol Endocrinol; 2017 Feb; 33(2):119-123. PubMed ID: 27690684
[TBL] [Abstract][Full Text] [Related]
8. Sfrp5 associates with beta-cell function in humans.
Carstensen-Kirberg M; Hatziagelaki E; Tsiavou A; Chounta A; Nowotny P; Pacini G; Dimitriadis G; Roden M; Herder C
Eur J Clin Invest; 2016 Jun; 46(6):535-43. PubMed ID: 27019073
[TBL] [Abstract][Full Text] [Related]
9. Activation of noncanonical Wnt signaling through WNT5A in visceral adipose tissue of obese subjects is related to inflammation.
Catalán V; Gómez-Ambrosi J; Rodríguez A; Pérez-Hernández AI; Gurbindo J; Ramírez B; Méndez-Giménez L; Rotellar F; Valentí V; Moncada R; Martí P; Sola I; Silva C; Salvador J; Frühbeck G
J Clin Endocrinol Metab; 2014 Aug; 99(8):E1407-17. PubMed ID: 24840810
[TBL] [Abstract][Full Text] [Related]
10. Adipokines, insulin-like growth factor binding protein-3 levels, and insulin sensitivity in women with polycystic ovary syndrome.
Lee H; Oh JY; Sung YA
Korean J Intern Med; 2013 Jul; 28(4):456-63. PubMed ID: 23864804
[TBL] [Abstract][Full Text] [Related]
11. Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance.
Yang S; Li Q; Zhong L; Song Y; Tian B; Cheng Q; Qing H; Xia W; Luo M; Mei M
J Clin Endocrinol Metab; 2011 Mar; 96(3):831-6. PubMed ID: 21209034
[TBL] [Abstract][Full Text] [Related]
12. The wingless-related integration site-5a/secreted frizzled-related protein-5 system is dysregulated in human sepsis.
Schulte DM; Kragelund D; Müller N; Hagen I; Elke G; Titz A; Schädler D; Schumacher J; Weiler N; Bewig B; Schreiber S; Laudes M
Clin Exp Immunol; 2015 Apr; 180(1):90-7. PubMed ID: 25382802
[TBL] [Abstract][Full Text] [Related]
13. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.
Robinson S; Henderson AD; Gelding SV; Kiddy D; Niththyananthan R; Bush A; Richmond W; Johnston DG; Franks S
Clin Endocrinol (Oxf); 1996 Mar; 44(3):277-84. PubMed ID: 8729522
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
Sepilian V; Nagamani M
J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
[TBL] [Abstract][Full Text] [Related]
15. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
Yang XF; Ren FR; Guo SP
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
[TBL] [Abstract][Full Text] [Related]
16. Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity.
Escobar-Morreale HF; Botella-Carretero JI; Villuendas G; Sancho J; San Millán JL
J Clin Endocrinol Metab; 2004 Feb; 89(2):806-11. PubMed ID: 14764799
[TBL] [Abstract][Full Text] [Related]
17. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M
J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
[TBL] [Abstract][Full Text] [Related]
19. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
20. Obesity and inflammatory biomarkers in women with polycystic ovary syndrome.
Shen SH; Shen SY; Liou TH; Hsu MI; Chang YC; Cheng CY; Hsu CS; Tzeng CR
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():66-71. PubMed ID: 26177495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
